{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:47:04Z","timestamp":1778687224297,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:p>\n            The renal outer medullary potassium channel (ROMK,\n            <jats:italic>KCNJ1<\/jats:italic>\n            ) mediates potassium recycling and facilitates sodium reabsorption through the Na\n            <jats:sup>+<\/jats:sup>\n            \/K\n            <jats:sup>+<\/jats:sup>\n            \/2Cl\n            <jats:sup>\u2212<\/jats:sup>\n            cotransporter in the loop of Henle and potassium secretion at the cortical collecting duct. Human genetic studies indicate that ROMK homozygous loss-of-function mutations cause type II Bartter syndrome, featuring polyuria, renal salt wasting, and hypotension; humans heterozygous for ROMK mutations identified in the Framingham Heart Study have reduced blood pressure. ROMK null mice recapitulate many of the features of type II Bartter syndrome. We have generated an ROMK knockout rat model in Dahl salt-sensitive background by using zinc finger nuclease technology and investigated the effects of knocking out ROMK on systemic and renal hemodynamics and kidney histology in the Dahl salt-sensitive rats. The ROMK\n            <jats:sup>\u2212\/\u2212<\/jats:sup>\n            pups recapitulated features identified in the ROMK null mice. The ROMK\n            <jats:sup>+\/\u2212<\/jats:sup>\n            rats, when challenged with a 4% salt diet, exhibited a reduced blood pressure compared with their ROMK\n            <jats:sup>+\/+<\/jats:sup>\n            littermates. More importantly, when challenged with an 8% salt diet, the Dahl salt-sensitive rats with 50% less ROMK expression showed increased protection from salt-induced blood pressure elevation and signs of protection from renal injury. Our findings in ROMK knockout Dahl salt-sensitive rats, together with the previous reports in humans and mice, underscore a critical role of ROMK in blood pressure regulation.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.111.01051","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T05:18:01Z","timestamp":1370927881000},"page":"288-294","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Heterozygous Disruption of Renal Outer Medullary Potassium Channel in Rats Is Associated With Reduced Blood Pressure"],"prefix":"10.1161","volume":"62","author":[{"given":"Xiaoyan","family":"Zhou","sequence":"first","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Kyun","family":"Shin","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Beth","family":"Horwitz","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Levorse","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Sharif-Rodriguez","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis Y.","family":"Streltsov","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Dajee","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melba","family":"Hernandez","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Pan","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Urosevic-Price","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Forrest","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Szeto","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghua","family":"Zhu","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Cui","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindhu","family":"Michael","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie Ann","family":"Balogh","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Welling","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Wade","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Roy","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"From the Departments of Cardiovascular Diseases (X.Z., W.S.-R., D.Y.S., M.D., M.H., S.R., K.A.S.), Genetically Engineered Models (Z.Z., M.K.S., S.B.H., J.M.L., L.Z.), In Vivo Pharmacology (Y.P., O.U.-P., L.W., G.F., D.S., Y.Z., Y.C.), and Safety Assessment and Laboratory Animal Resources (B.M., L.A.B.), Merck Research Laboratories, Merck &amp; Co, Inc, Rahway, NJ; and Department of Physiology, University of Maryland School of Medicine, Baltimore, MD (P.A.W., J.B.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2541"},{"key":"e_1_3_4_3_2","first-page":"221","article-title":"A new familial disorder characterized by hypokalemia and hypomagnesemia.","volume":"79","author":"Gitelman HJ","year":"1966","unstructured":"Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians. 1966;79:221\u2013235.","journal-title":"Trans Assoc Am Physicians"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0196-24"},{"key":"e_1_3_4_5_2","first-page":"1019","article-title":"Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome.","volume":"59","author":"Mastroianni N","year":"1996","unstructured":"Mastroianni N, Bettinelli A, Bianchetti M, Colussi G, De Fusco M, Sereni F, Ballabio A, Casari G. Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome. Am J Hum Genet. 1996;59:1019\u20131026.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V11165"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/imj.1970.19.4.287"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062844"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0696-183"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1096-152"},{"key":"e_1_3_4_11_2","first-page":"17","article-title":"Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity.","volume":"6","author":"International Collaborative Study Group for Bartter-Like Syndromes","year":"1997","unstructured":"International Collaborative Study Group for Bartter-Like Syndromes. Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. Hum Molec Genet. 1997;6:17\u201326.","journal-title":"Hum Molec Genet"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590051803.x"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.118"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/362031a0"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00181.2009"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205627200"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206644200"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00608.2007"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00613.2007"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-389-3_15"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.111.074179"},{"issue":"1","key":"e_1_3_4_22_2","first-page":"F57","article-title":"Abnormal renal hemodynamics and pressure-natriuresis relationship in Dahl salt-sensitive rats.","volume":"251","author":"Roman RJ","year":"1986","unstructured":"Roman RJ. Abnormal renal hemodynamics and pressure-natriuresis relationship in Dahl salt-sensitive rats. Am J Physiol. 1986;251(1 pt2):F57\u2013F65.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.7.2407"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000070028.99408.e8"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.17.1_suppl.i52"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)01086-5"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.100"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-006-6011-0"},{"issue":"6","key":"e_1_3_4_29_2","first-page":"F825","article-title":"Developmental expression of ROMK in rat kidney.","volume":"276","author":"Zolotnitskaya A","year":"1999","unstructured":"Zolotnitskaya A, Satlin LM. Developmental expression of ROMK in rat kidney. Am J Physiol. 1999;276(6 pt 2):F825\u2013F836.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00806.x"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V11111987"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1095-6433(00)00214-2"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/13.suppl_G.2"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.43"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2063193"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.15.6.547"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000120123.44945.47"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.17.6.1018"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.111.01051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:21:30Z","timestamp":1715592090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.111.01051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.111.01051"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.111.01051","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"2013-01-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-04-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-06-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}